Baird analyst Vikram Kesavabhotla raised the firm’s price target on Doximity to $31 from $29 and keeps an Outperform rating on the shares. The firm said they reported strong F3Q results and offered F4Q guidance that was a touch below consensus.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on DOCS:
